A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mavorixafor | CAS 558447-26-0 - Request Quote

Picture of Mavorixafor
SZ CAT No:SZ-M172001
CAS No
558447-26-0
Mol.F.
C21H27N5
Mol.Wt.
349.5
Inv. Status
Synthesis on demand
Rel. CAS No880549-30-4 (HCl salt) ; 880549-32-6 (sulfate salt)
Shipping Condition Room Temperature

Chemical Name :

Synonym :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Mavorixafor is chemically (S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine. It is also known as Xolremdi. Mavorixafor is supplied with detailed characterization data compliant with regulatory guideline. Mavorixafor can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mavorixafor.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 558447-26-0

Purchase 558447-26-0

Order 558447-26-0

Enquire 558447-26-0

price of 558447-26-0

558447-26-0 Supplier

558447-26-0 Manufacturer

558447-26-0 Exporter

buy high quality Mavorixafor

Purchase Mavorixafor

Mavorixafor suppliers

Mavorixafor manufacturers

Mavorixafor price

Order Mavorixafor

Enquire Mavorixafor

Mavorixafor cost

Mavorixafor Supplier

Mavorixafor Distributor

Mavorixafor for Method Validation

Mavorixafor Reference Standard

Mavorixafor for ANDA Filing

Mavorixafor for Forced Degradation Studies

Mavorixafor Identification Standards

Mavorixafor for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,